Back to Results
First PageMeta Content
Receptor antagonist / Insulin-degrading enzyme / Ligand / Agonist / G protein-coupled receptor / Receptor / Allosteric regulation / IC50 / NMDA receptor / Biology / Cell biology / Cell signaling


0026-895X[removed]–72$3.00 MOLECULAR PHARMACOLOGY Copyright © 2002 The American Society for Pharmacology and Experimental Therapeutics Mol Pharmacol 61:65–72, 2002 Vol. 61, No. 1
Add to Reading List

Document Date: 2009-12-04 19:09:07

Open Document

File Size: 242,29 KB

Share Result on Facebook

City

Louis / Mannheim / Diego / Indianapolis / Hercules / Boston / San Diego / Milwaukee / St. Louis / /

Company

Mallinckrodt / Hjorth SA / Fisher Scientific / Bio-Rad / PerkinElmer / Gilman AG / EP (1997) Metal / GraphPad Software / /

Country

Germany / /

Currency

USD / /

/

Facility

cAMP Accumulation / TAE WEON LEE Howard Hughes Medical Institute / Stanford University / Isoproterenol-Stimulated cAMP Accumulation / /

IndustryTerm

metal / lowaffinity site / endogenous zinc-binding site / agonist site / chelator site / urea solution / metal-ion-binding sites linking transmembrane helices / engineered metal ion binding / divalent cation binding site / affinity site / metal cations / /

Organization

Stanford University Medical School / Stanford University / Beckman Center / Mathers Charitable Foundation / American Society for Pharmacology and Experimental Therapeutics Mol Pharmacol / American Society for Pharmacology / TAE WEON LEE Howard Hughes Medical Institute / Stanford / /

Person

JACQUELINE STEENHUIS / BRIAN KOBILKA / TAE WEON LEE / F. Nature (Lond) / /

Position

novel ionic mediator / representative / /

Product

zinc chloride / /

ProvinceOrState

South Dakota / California / /

SportsLeague

Stanford University / /

Technology

alpha / /

URL

http /

SocialTag